126 related articles for article (PubMed ID: 36250993)
1. Hypermethylation of RASSF1A gene in pediatric rhabdoid tumor of the kidney and clear cell sarcoma of the kidney.
Ueno-Yokohata H; Okita H; Nakasato K; Kiyokawa N
Pediatr Blood Cancer; 2023 Feb; 70(2):e30058. PubMed ID: 36250993
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profile distinguishes clear cell sarcoma of the kidney from other pediatric renal tumors.
Ueno H; Okita H; Akimoto S; Kobayashi K; Nakabayashi K; Hata K; Fujimoto J; Hata J; Fukuzawa M; Kiyokawa N
PLoS One; 2013; 8(4):e62233. PubMed ID: 23638012
[TBL] [Abstract][Full Text] [Related]
3. Functional and gene expression analysis of the p53 signaling pathway in clear cell sarcoma of the kidney and congenital mesoblastic nephroma.
Brownlee NA; Hazen-Martin DJ; Garvin AJ; Re GG
Pediatr Dev Pathol; 2002; 5(3):257-68. PubMed ID: 12007018
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
5. Classification of malignant pediatric renal tumors by gene expression.
Huang CC; Cutcliffe C; Coffin C; Sorensen PH; Beckwith JB; Perlman EJ;
Pediatr Blood Cancer; 2006 Jun; 46(7):728-38. PubMed ID: 16425275
[TBL] [Abstract][Full Text] [Related]
6. Frequent methylation of RASSF1A in synovial sarcoma and the anti-tumor effects of 5-aza-2'-deoxycytidine against synovial sarcoma cell lines.
Numoto K; Yoshida A; Sugihara S; Kunisada T; Morimoto Y; Yoneda Y; Fujita Y; Nishida K; Ouchida M; Ozaki T
J Cancer Res Clin Oncol; 2010 Jan; 136(1):17-25. PubMed ID: 19578875
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Renal Tumors: Updates in the Molecular Era.
Treece AL
Surg Pathol Clin; 2020 Dec; 13(4):695-718. PubMed ID: 33183728
[TBL] [Abstract][Full Text] [Related]
8. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.
Shen WJ; Dai DQ; Teng Y; Liu HB
World J Gastroenterol; 2008 Jan; 14(4):595-600. PubMed ID: 18203293
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma.
Tokinaga K; Okuda H; Nomura A; Ashida S; Furihata M; Shuin T
Oncol Rep; 2004 Oct; 12(4):805-10. PubMed ID: 15375503
[TBL] [Abstract][Full Text] [Related]
10. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
Zuo S; Chen Y; Xu L; Tang Q; Zou S
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
[TBL] [Abstract][Full Text] [Related]
11. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
[TBL] [Abstract][Full Text] [Related]
12. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.
Dreijerink K; Braga E; Kuzmin I; Geil L; Duh FM; Angeloni D; Zbar B; Lerman MI; Stanbridge EJ; Minna JD; Protopopov A; Li J; Kashuba V; Klein G; Zabarovsky ER
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7504-9. PubMed ID: 11390984
[TBL] [Abstract][Full Text] [Related]
13. [The Role of 5-Aza-CdR on Methylation of Promoter in RASSF1A Gene in Endometrial Carcinoma].
Huang LP; Chen C; Wang XP; Liu H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):380-3. PubMed ID: 26121857
[TBL] [Abstract][Full Text] [Related]
14. Beyond Wilms tumor: imaging findings and outcomes of rare renal tumors in children.
Ayaz E; Ozcan HN; Oguz B; Haliloglu M
Pediatr Radiol; 2022 Dec; 52(13):2557-2567. PubMed ID: 35760918
[TBL] [Abstract][Full Text] [Related]
15. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line].
Yang J; Ji W; Qu Y; He L; Zhao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(2):64-6. PubMed ID: 21473137
[TBL] [Abstract][Full Text] [Related]
16. Role of Cyclin D1 and BCOR Immunohistochemistry in Differentiating Clear Cell Sarcoma of Kidney From its Mimics.
Singh V; Gupta K; Saraswati A; Peters NJ; Trehan A
J Pediatr Hematol Oncol; 2021 Nov; 43(8):294-300. PubMed ID: 34673711
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.
Mühlisch J; Schwering A; Grotzer M; Vince GH; Roggendorf W; Hagemann C; Sörensen N; Rickert CH; Osada N; Jürgens H; Frühwald MC
Oncogene; 2006 Feb; 25(7):1111-7. PubMed ID: 16186793
[TBL] [Abstract][Full Text] [Related]
18. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney.
Mirkovic J; Calicchio M; Fletcher CD; Perez-Atayde AR
Histopathology; 2015 Sep; 67(3):306-12. PubMed ID: 25556515
[TBL] [Abstract][Full Text] [Related]
19. Non-Wilms' renal tumors in children: experience with 139 cases treated at a single center.
Fang YW; Song HC; Sun N; Zhang WP
BMC Urol; 2022 Jun; 22(1):89. PubMed ID: 35733141
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of RASSF1A in head and neck cancer.
Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
